LiquiGlide Closes $16 Million in Funding
CAMBRIDGE, MA – LiquiGlide Inc. has closed $16 million in new financing. Investors that played a key role in the funding include Structure Capital, Valia Investments, Struck Capital and Pilot Grove. LiquiGlide will use the capital to grow its existing packaging business while also accelerating the commercialization of new coating applications in the industrial and food manufacturing markets.
As part of the investment, Jillian Manus, Managing Partner at Structure Capital, a seed and early stage venture fund providing capital and marketing strategy to companies working to eliminate waste, has been named to LiquiGlide’s board of directors. Commenting on the investment in LiquiGlide, Manus said, “Structure Capital’s mission is to be the architects of a zero-waste economy, and LiquiGlide’s slippery coating technology redefines the elimination of waste. As a board member, I look forward to being a strategic advisor for the company as it prepares to make a real impact on waste and inefficiency in industrial markets.”
LiquiGlide’s patented technology platform for permanently wet, slippery surface coatings was developed at the Massachusetts Institute of Technology (MIT) by Professor Kripa Varanasi and Dave Smith, who co-founded LiquiGlide Inc. LiquiGlide’s coatings are custom-made for each application by combining a porous solid with a liquid that gets trapped within it via strong capillary forces.
“Our technology has always had applications across a variety of industries,” said LiquiGlide co-founder and CEO Dave Smith. “Having developed successful partnerships in packaging, the area of our initial focus, this capital gives us the opportunity to not only continue to grow and support initiatives in packaging, but also accelerate our growth in industrial markets – an area where we see tremendous potential to help companies reduce waste and improve energy efficiency.”
The $16 million infusion adds to the $7 million LiquiGlide received from Roadmap Capital in March 2015, which allowed the company to secure commercial deals in multiple market verticals, build a state-of-the-art laboratory and office space in Cambridge, and attract top scientists.
Looking for a reprint of this article?
From high-res PDFs to custom plaques, order your copy today!
